DOVONEX Side Effects

6973995-X | Product Container Issue, Skin Laceration
on Dec 22, 2009 Female patient from CANADA , 47 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: product container issue, skin laceration. Dovonex dosage: 2 Application (2 In 1 D), Topical. During the same period patient was treated with TACLONEX (View Taclonex Review and Taclonex Label ).

6959651-2 | Decreased Appetite, Dehydration, Hypercalcaemia, Malaise, Rash Pustular, Renal Failure Acute, Tremor
Patient was taking Dovonex (View Usage). Patient had the following side effects: decreased appetite, dehydration, hypercalcaemia, malaise, rash pustular, renal failure acute, tremor on Aug 13, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with psoriasis and. Dovonex dosage: 8-10 Gram (2 In 1 D), Topical. During the same period patient was treated with CYCLOSPORINE (7 Gm (3.5 Gm, 2 In 1 D), Oral) (View Cyclosporine Review and Cyclosporine Label ), OXAROL (MAXACALCITOL) (7.5 Gm (3.75 Gm, 2 In 1 D), Topical) (View Oxarol (maxacalcitol) Review and Oxarol (maxacalcitol) Label ), FAMOTIDINE (FAMOTIDINE) (TABLETS) (View Famotidine (famotidine) (tablets) Review and Famotidine (famotidine) (tablets) Label ), ALESION (EPINASTINE HYDROCHLORIDE) (TABLETS) (View Alesion (epinastine Hydrochloride) (tablets) Review and Alesion (epinastine Hydrochloride) (tablets) Label ), DIFLUPREDNATE (DIFLUPERDNATE) (OINTMENT) (View Difluprednate (difluperdnate) (ointment) Review and Difluprednate (difluperdnate) (ointment) Label ), ETIZOLAM (ETIZOLAM) (TABLETS) (View Etizolam (etizolam) (tablets) Review and Etizolam (etizolam) (tablets) Label ), ALLELOCK (OLOPATADINE HYDROCHLORIDE) (TABLETS) (View Allelock (olopatadine Hydrochloride) (tablets) Review and Allelock (olopatadine Hydrochloride) (tablets) Label ).

6919652-7 | Blood Creatinine Increased, Dehydration, Hypercalcaemia
Adverse event was reported on Jul 27, 2010 by a Female patient taking Dovonex (View Usage) (Dosage: 20 Gm, Topical) was diagnosed with psoriasis and. Location: JAPAN , 60 years of age, After Dovonex was administered, patient had the following side effects: blood creatinine increased, dehydration, hypercalcaemia. During the same period patient was treated with CYCLOSPORINE (150 Mg) (View Cyclosporine Review and Cyclosporine Label ), OXAROL (MAXACALCITOL) (View Oxarol (maxacalcitol) Review and Oxarol (maxacalcitol) Label ).

6905982-1 | Dysgeusia, Gingival Bleeding
on Feb 08, 1995 Female patient from UNITED KINGDOM , 63 years of age, weighting 116.8 lb, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, gingival bleeding. Dovonex dosage: Topical. During the same period patient was treated with WARFARIN SODIUM (1 Mg Bd Nocte Or 3 Mg), Oral) (View Warfarin Sodium Review and Warfarin Sodium Label ), ZANTAC 150 (View Zantac 150 Review and Zantac 150 Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), INNOVACE (ENALAPRIL MALEATE) (View Innovace (enalapril Maleate) Review and Innovace (enalapril Maleate) Label ), POLYTAR LIQUID (COAL TAR) (View Polytar Liquid (coal Tar) Review and Polytar Liquid (coal Tar) Label ), HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ), TRIMOVATE (NYSTATIN) (NYSTATIN, OXYTETRACYCLINE CALCIUM, CLOBETASONE B (View Trimovate (nystatin) (nystatin, Oxytetracycline Calcium, Clobetasone B Review and Trimovate (nystatin) (nystatin, Oxytetracycline Calcium, Clobetasone B Label ). Patient was hospitalized.


6812242-6 | Emotional Distress
on May 12, 2010 Female patient from UNITED KINGDOM , 62 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient had the following side effects: emotional distress. Dovonex dosage: 2 In 1 D), Topical.

6723577-X | Emotional Distress
Patient was taking Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: emotional distress on Apr 29, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 62 years of age, was diagnosed with psoriasis and. Dovonex dosage: 2 In 1 D, Topical.

6721502-9 | Condition Aggravated, Decreased Appetite, Dehydration, Erythema, Hypercalcaemia, Off Label Use, Renal Failure, Skin Atrophy, Skin Disorder
Adverse event was reported on Dec 09, 2009 by a Female patient taking Dovonex (View Usage) (Dosage: (10 Gm),topical ; (5 Gm),topical) was diagnosed with pityriasis rubra pilaris and. Location: JAPAN , 86 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, decreased appetite, dehydration, erythema, hypercalcaemia, off label use, renal failure, skin atrophy, skin disorder. During the same period patient was treated with VASOLAN (VERAPAMIL HYDROCHLORIDE) (TABLETS) (View Vasolan (verapamil Hydrochloride) (tablets) Review and Vasolan (verapamil Hydrochloride) (tablets) Label ), ITOROL (ISOSORBIDE MONONITRATE) (TABLETS) (View Itorol (isosorbide Mononitrate) (tablets) Review and Itorol (isosorbide Mononitrate) (tablets) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MUCODYNE (CARBOCISTEINE) (TABLETS) (View Mucodyne (carbocisteine) (tablets) Review and Mucodyne (carbocisteine) (tablets) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), TIGASON (ETRETINATE) (CAPSULES) (View Tigason (etretinate) (capsules) Review and Tigason (etretinate) (capsules) Label ). Patient was hospitalized.

6654177-8 | Hypersensitivity
on Mar 12, 2010 Female patient from UNITED KINGDOM , 65 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient had the following side effects: hypersensitivity. Dovonex dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (ATENOLOL) (View Atenolol (atenolol) Review and Atenolol (atenolol) Label ), BENDROFLUMETHIAZIDE (BENDROFLUMETHIAZIDE) (View Bendroflumethiazide (bendroflumethiazide) Review and Bendroflumethiazide (bendroflumethiazide) Label ), DOUBLEBASE (ISOPROPYL MYRISTATE, PARAFFIN, LIQUID) (View Doublebase (isopropyl Myristate, Paraffin, Liquid) Review and Doublebase (isopropyl Myristate, Paraffin, Liquid) Label ), XEMESTANE (EXEMESTANE) (View Xemestane (exemestane) Review and Xemestane (exemestane) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6536909-2 | Application Site Irritation, Application Site Pain, Photosensitivity Reaction
on Dec 22, 2009 Female patient from UNITED KINGDOM , 44 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: application site irritation, application site pain, photosensitivity reaction. Dovonex dosage: Topical.

6438223-2 | Nephrolithiasis
Patient was taking Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis on Oct 22, 2009 from UNITED STATES Additional patient health information: Male patient , 76 years of age, . Dovonex dosage: Topical. During the same period patient was treated with TACLONEX (Topical) (View Taclonex Review and Taclonex Label ).

6417035-X | Dermatitis Allergic, Dermatitis Contact
Adverse event was reported on Oct 15, 2009 by a Female patient taking Dovonex (View Usage) (Dosage: Unk, Topical) was diagnosed with psoriasis and. Location: UNITED KINGDOM , 53 years of age, Patient had the following side effects: dermatitis allergic, dermatitis contact. During the same period patient was treated with AQUEOUS (EMULSIFYING WAX, PARAFFIN, LIQUID, WHITE SOFT PARAFFIN) CREAM (View Aqueous (emulsifying Wax, Paraffin, Liquid, White Soft Paraffin) Cream Review and Aqueous (emulsifying Wax, Paraffin, Liquid, White Soft Paraffin) Cream Label ).

6269381-0 | Condition Aggravated, Dermatitis Contact, Hypersensitivity, Psoriasis
on Jun 29, 2009 Female patient from JAPAN , 66 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: condition aggravated, dermatitis contact, hypersensitivity, psoriasis. Dovonex dosage: 3 G, Qd, Topical. During the same period patient was treated with BETAMETHASONE (BETAMETHASONE) OINTMENT (View Betamethasone (betamethasone) Ointment Review and Betamethasone (betamethasone) Ointment Label ). Patient was hospitalized and became disabled.

6266244-1 | Gout, Overdose
on Jun 24, 2009 Male patient from DENMARK , 54 years of age, was treated with Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: gout (What is gout?), overdose. Dovonex dosage: .

6260612-X | Blood Glucose Increased, Blood Immunoglobulin A Increased, Glomerulonephritis, Glycosuria, Hypertension, Proteinuria, Renal Tubular Disorder
Patient was taking Dovonex (View Usage). Patient had the following side effects: blood glucose increased, blood immunoglobulin a increased, glomerulonephritis, glycosuria, hypertension, proteinuria, renal tubular disorder on Jun 18, 2009 from DENMARK Additional patient health information: Male patient , 58 years of age, was diagnosed with psoriasis, psoriatic arthropathy and. Dovonex dosage: 2 Df, Topical. During the same period patient was treated with SULFASALAZINE (2000 Mg Daily (500 Mg Qid), Oral; 1500 Mg (500 Mg Tid), Oral; 1000 Mg (500 Mg Bid), Oral) (View Sulfasalazine Review and Sulfasalazine Label ).

6249989-9 | Skin Cancer
Adverse event was reported on Jun 16, 2009 by a Female patient taking Dovonex (View Usage) (Dosage: Topical) was diagnosed with psoriasis and. Location: UNITED STATES , 70 years of age, weighting 164.9 lb, After Dovonex was administered, patient had the following side effects: skin cancer (What is skin cancer?). During the same period patient was treated with INSULIN (INSULIN) INJECTION (View Insulin (insulin) Injection Review and Insulin (insulin) Injection Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LEVOCOR (View Levocor Review and Levocor Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ).

6203765-1 | Skin Cancer
on May 11, 2009 Female patient from UNITED STATES , 70 years of age, weighting 164.9 lb, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: skin cancer (What is skin cancer?). Dovonex dosage: Topical. During the same period patient was treated with INSULIN (INSULIN) INJECTION (View Insulin (insulin) Injection Review and Insulin (insulin) Injection Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LEVOCOR (View Levocor Review and Levocor Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ).

6202871-5 | Photosensitivity Reaction
on May 05, 2009 Female patient from UNITED KINGDOM , 44 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient had the following side effects: photosensitivity reaction. Dovonex dosage: Topical ; Apply To Face Twice Daily.

6036402-X | Nephrolithiasis
Patient was taking Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: nephrolithiasis on Dec 22, 2008 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 224.9 lb, was diagnosed with psoriasis and. Dovonex dosage: 0.005%, Topical. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6030940-1 | Dermatosis, Off Label Use, Skin Test Positive
Adverse event was reported on Dec 23, 2008 by a Male patient taking Dovonex (View Usage) (Dosage: Topical) was diagnosed with seborrhoeic dermatitis and. Location: FRANCE , 37 years of age, Patient experienced the following unwanted or unexpected effects: dermatosis, off label use, skin test positive. During the same period patient was treated with FAZOL(ISOCONAZOL NITRATE) (Topical) (View Fazol(isoconazol Nitrate) Review and Fazol(isoconazol Nitrate) Label ), EURAX (Topical) (View Eurax Review and Eurax Label ), LOCOID (Topical) (View Locoid Review and Locoid Label ). Patient was hospitalized.

5824645-7 | Angina Pectoris
on Jul 09, 2008 Male patient from ITALY , 66 years of age, was treated with Dovonex (View Usage). Patient had the following side effects: angina pectoris. Dovonex dosage: Topical. Patient was hospitalized.

5810550-9 | Angina Pectoris
on Jun 24, 2008 Male patient from ITALY , 66 years of age, was treated with Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: angina pectoris. Dovonex dosage: . Patient was hospitalized.

5810520-0 | Myocardial Infarction
Patient was taking Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction on Jun 23, 2008 from DENMARK Additional patient health information: Male patient , 76 years of age, . Dovonex dosage: Topical. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5712043-6 | Arthralgia, Hepatic Enzyme Increased, Immobile, Joint Stabilisation, Red Blood Cell Sedimentation Rate Increased
Adverse event was reported on Apr 04, 2008 by a Female patient taking Dovonex (View Usage) (Dosage: 0.005% Qd, Topical) was diagnosed with psoriasis and. Location: CANADA , 34 years of age, Patient had the following side effects: arthralgia, hepatic enzyme increased, immobile, joint stabilisation, red blood cell sedimentation rate increased. During the same period patient was treated with TACLONEX (0.005/.064%, Topical) (View Taclonex Review and Taclonex Label ), VALACICLOVIR (VALACICLOVIR), 2G (View Valaciclovir (valaciclovir), 2g Review and Valaciclovir (valaciclovir), 2g Label ), REMICADE (INFLIXIMAB) INFUSION, 1.7857 MG (View Remicade (infliximab) Infusion, 1.7857 Mg Review and Remicade (infliximab) Infusion, 1.7857 Mg Label ).

5708187-5 | Anaemia, Anorexia, Blood Pressure Decreased, Cardiomegaly, Dehydration, Depressed Level Of Consciousness, Dry Mouth, Hypercalcaemia, Hypernatraemia
on Mar 28, 2008 Female patient from JAPAN , 85 years of age, weighting 136.0 lb, was diagnosed with psoriasis, osteoporosis prophylaxis and was treated with Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: anaemia, anorexia, blood pressure decreased, cardiomegaly, dehydration, depressed level of consciousness, dry mouth, hypercalcaemia, hypernatraemia. Dovonex dosage: 0.005%; Qd, Topical. During the same period patient was treated with CALCIUM LACTATE(CALCIUM LACTATE) (View Calcium Lactate(calcium Lactate) Review and Calcium Lactate(calcium Lactate) Label ). Patient was hospitalized.

5706351-2 | Abdominal Pain, Blood Calcium Increased, Incorrect Dose Administered, Muscular Weakness, Nausea, Renal Impairment
on Mar 31, 2008 Female patient from UNITED KINGDOM , 67 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood calcium increased, incorrect dose administered, muscular weakness, nausea (What is nausea?), renal impairment. Dovonex dosage: 0.005 %, Bid, Topical.

5706328-7 | Blood Creatinine Increased, Dizziness, Fatigue, Hypercalcaemia, Myalgia, Nausea, Weight Decreased
Patient was taking Dovonex (View Usage). Patient had the following side effects: blood creatinine increased, dizziness (What is dizziness?), fatigue, hypercalcaemia, myalgia, nausea (What is nausea?), weight decreased on Mar 29, 2008 from DENMARK Additional patient health information: Female patient , 17 years of age, was diagnosed with ichthyosis and. Dovonex dosage: 0.005%, Bid, Topical. During the same period patient was treated with ACITRETIN (View Acitretin Review and Acitretin Label ).

5612238-6 | Musculoskeletal Pain, Pain In Extremity, Paraesthesia, Skin Exfoliation, Thermal Burn
Adverse event was reported on Jan 14, 2008 by a Male patient taking Dovonex (View Usage) (Dosage: ) was diagnosed with psoriasis, hepatitis (What is hepatitis?) and. Location: FRANCE , 48 years of age, After Dovonex was administered, patient had the following side effects: musculoskeletal pain, pain in extremity, paraesthesia, skin exfoliation, thermal burn. During the same period patient was treated with TACLONEX (View Taclonex Review and Taclonex Label ), ENTECAVIR() TABLET, .50MG (0.5, Qd, Oral) (View Entecavir() Tablet, .50mg Review and Entecavir() Tablet, .50mg Label ). Patient was hospitalized.

5489256-4 | Condition Aggravated, Lipoma, Psoriasis
on Oct 04, 2007 Female patient from UNITED STATES , 41 years of age, weighting 123.9 lb, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, lipoma, psoriasis. Dovonex dosage: 0.005 %, Bid, Topical. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

5475873-4 | Dermatitis Contact
on May 24, 2007 Male patient from UNITED STATES , 60 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient had the following side effects: dermatitis contact. Dovonex dosage: Qd, Topical. During the same period patient was treated with CORTICOSTEROID NOS (CORTICOSTEROID NOS) (View Corticosteroid Nos (corticosteroid Nos) Review and Corticosteroid Nos (corticosteroid Nos) Label ). Patient was hospitalized.

5419341-4 | Cerebrovascular Accident, Psoriasis
Patient was taking Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: cerebrovascular accident, psoriasis on Aug 01, 2007 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 291.9 lb, was diagnosed with psoriasis and. Dovonex dosage: Qd, Topical. During the same period patient was treated with TRICOR /00499301/ (FENOFIBRATE) (View Tricor /00499301/ (fenofibrate) Review and Tricor /00499301/ (fenofibrate) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), LASIX (View Lasix Review and Lasix Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FLOVENT (View Flovent Review and Flovent Label ), ALBUTEROL /00139501/ (SALBUTAMOL) (View Albuterol /00139501/ (salbutamol) Review and Albuterol /00139501/ (salbutamol) Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5332843-4 | Hypercalcaemia, Incorrect Dose Administered, Renal Failure
Adverse event was reported on May 09, 2007 by a Male patient taking Dovonex (View Usage) (Dosage: 30 G/week, Topical) was diagnosed with psoriasis and. Location: GERMANY , 47 years of age, Patient experienced the following unwanted or unexpected effects: hypercalcaemia, incorrect dose administered, renal failure. During the same period patient was treated with CYCLOSPORINE (100-200 Mg, Qd, Oral) (View Cyclosporine Review and Cyclosporine Label ), MAGNESIUM (MAGNESIUM) (View Magnesium (magnesium) Review and Magnesium (magnesium) Label ). Patient was hospitalized.

5291401-0 | Blister, Discomfort, Feeling Hot
on Mar 16, 2007 Male patient from NETHERLANDS , 51 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient had the following side effects: blister, discomfort, feeling hot. Dovonex dosage: Topical.

5282561-6 | Accident, Arthralgia, Condition Aggravated, Diabetes Mellitus Insulin-dependent, Dysgeusia, Gait Disturbance, Head Injury, Pruritus
on Mar 15, 2007 Male patient from UNITED STATES , 46 years of age, weighting 175.0 lb, was diagnosed with psoriasis and was treated with Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: accident, arthralgia, condition aggravated, diabetes mellitus insulin-dependent, dysgeusia, gait disturbance, head injury, pruritus. Dovonex dosage: 0.005 %, Bid, Topical. Patient was hospitalized.

5274727-6 | Nephrolithiasis
Patient was taking Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis on Mar 05, 2007 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 134.9 lb, was diagnosed with psoriasis and. Dovonex dosage: See Image.

5245911-2 | Condition Aggravated, Haemorrhage, Psoriasis
Adverse event was reported on Feb 09, 2007 by a Male patient taking Dovonex (View Usage) (Dosage: Unk, Unk. Topical) was diagnosed with psoriasis and. Location: UNITED KINGDOM , 63 years of age, Patient had the following side effects: condition aggravated, haemorrhage, psoriasis.

5228700-4 | Dermatitis Contact, Pain, Photosensitivity Reaction
on Jan 16, 2007 Female patient from ITALY , 56 years of age, was treated with Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: dermatitis contact, pain (What is pain?), photosensitivity reaction. Dovonex dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), GLYBURIDE AND METFORMIN HCL (View Glyburide And Metformin Hcl Review and Glyburide And Metformin Hcl Label ). Patient was hospitalized.

5148779-8 | Nephrolithiasis, Pain
on Oct 25, 2006 Male patient from UNITED STATES , 79 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis, pain (What is pain?). Dovonex dosage: Unk, Qd, Topical. During the same period patient was treated with DOVONEX (CALCIPOTRIENE) CREAM (View Dovonex (calcipotriene) Cream Review and Dovonex (calcipotriene) Cream Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), KENALOG (View Kenalog Review and Kenalog Label ), BETAMETHISONE (View Betamethisone Review and Betamethisone Label ).

5105298-2 | C-reactive Protein Increased, Condition Aggravated, Pustular Psoriasis, Pyrexia, Skin Irritation, White Blood Cell Count Increased
Patient was taking Dovonex (View Usage). Patient had the following side effects: c-reactive protein increased, condition aggravated, pustular psoriasis, pyrexia, skin irritation, white blood cell count increased on Aug 28, 2006 from JAPAN Additional patient health information: Male patient , 55 years of age, was diagnosed with pustular psoriasis and. Dovonex dosage: 6 G/day, Topical. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), TIGASON (View Tigason Review and Tigason Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ). Patient was hospitalized.

5079232-8 | Dermatitis
Adverse event was reported on Jul 25, 2006 by a Female patient taking Dovonex (View Usage) (Dosage: ) . Location: FRANCE , 58 years of age, After Dovonex was administered, patient had the following side effects: dermatitis. During the same period patient was treated with TACLONEX(CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE) OINTMENT, .005/0.0 (View Taclonex(calcipotriene, Betamethasone Dipropionate) Ointment, .005/0.0 Review and Taclonex(calcipotriene, Betamethasone Dipropionate) Ointment, .005/0.0 Label ). Patient was hospitalized.

5042405-4 | Blood Pressure Increased
on Jun 09, 2006 Male patient from JAPAN , 68 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased. Dovonex dosage: 1 Application Tid, Topical. During the same period patient was treated with DIPROCOL (View Diprocol Review and Diprocol Label ).

5031761-9 | Erythema, Leukocytoclastic Vasculitis, Rash Papular, Skin Lesion
on Jun 02, 2006 Female patient from SWEDEN , 70 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient had the following side effects: erythema, leukocytoclastic vasculitis, rash papular, skin lesion. Dovonex dosage: 2.00 Df, Qd, Topical.

4991734-9 | Condition Aggravated, Eczema Infected, Hypercholesterolaemia, Hyperkeratosis, Hypersensitivity, Skin Test Positive
Patient was taking Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: condition aggravated, eczema infected, hypercholesterolaemia, hyperkeratosis, hypersensitivity, skin test positive on Apr 27, 2006 from FRANCE Additional patient health information: Female patient , 47 years of age, was diagnosed with psoriasis and. Dovonex dosage: 0, Topical. During the same period patient was treated with DIPROLENE (View Diprolene Review and Diprolene Label ). Patient was hospitalized.

4989036-X | Eczema Infected, Hyperkeratosis, Hypersensitivity
Adverse event was reported on Apr 10, 2006 by a Female patient taking Dovonex (View Usage) (Dosage: ) . Location: FRANCE , 47 years of age, Patient experienced the following unwanted or unexpected effects: eczema infected, hyperkeratosis, hypersensitivity. Patient was hospitalized.

4977145-0 | Condition Aggravated, Dermatitis Psoriasiform, Erythema, Pustular Psoriasis, Rash
on Mar 29, 2006 Male patient from UNITED STATES , 63 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). Patient had the following side effects: condition aggravated, dermatitis psoriasiform, erythema, pustular psoriasis, rash (What is rash?). Dovonex dosage: 0.005%, Qd, Topical. During the same period patient was treated with FLUTICASONE PROPIONATE (Qd, Topical) (View Fluticasone Propionate Review and Fluticasone Propionate Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CISAPRIDE (CISAPRIDE) (View Cisapride (cisapride) Review and Cisapride (cisapride) Label ). Patient was hospitalized.

4920101-9 | Application Site Erythema, Pyrexia, Rash, Skin Exfoliation, Skin Haemorrhage, Somnolence
on Jan 31, 2006 Male patient from UNITED KINGDOM , 36 years of age, was diagnosed with psoriasis and was treated with Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: application site erythema, pyrexia, rash (What is rash?), skin exfoliation, skin haemorrhage, somnolence. Dovonex dosage: , Qd, Topical. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).

4911997-5 | Application Site Erythema, Pyrexia, Skin Exfoliation, Skin Haemorrhage
Patient was taking Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: application site erythema, pyrexia, skin exfoliation, skin haemorrhage on Jan 31, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 36 years of age, . Dovonex dosage: Topical.

4888443-3 |
Adverse event was reported on Jan 04, 2006 by a Female patient taking Dovonex (View Usage) (Dosage: Topical) . Location: UNITED STATES , 90 years of age, .

4859924-3 | Erythema, Pruritus
on Sep 13, 2005 Female patient from UNITED STATES , 65 years of age, weighting 130.1 lb, was diagnosed with psoriasis and was treated with Dovonex (View Usage). After Dovonex was administered, patient had the following side effects: erythema, pruritus. Dovonex dosage: .

4859921-8 | Haemorrhage Subcutaneous, Skin Exfoliation
on Jul 15, 2005 Female patient from UNITED STATES , 13 years of age, was treated with Dovonex (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage subcutaneous, skin exfoliation. Dovonex dosage: . During the same period patient was treated with NIZORAL (Shampoo) (View Nizoral Review and Nizoral Label ), SELENIUM SULFIDE (View Selenium Sulfide Review and Selenium Sulfide Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).

4859917-6 | Skin Exfoliation
Patient was taking Dovonex (View Usage). Patient had the following side effects: skin exfoliation on Mar 21, 2005 from UNITED STATES Additional patient health information: Female patient , 37 years of age, weighting 141.1 lb, was diagnosed with psoriasis and. Dovonex dosage: .